Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Optimal clinical management of children receiving the ketogenic diet: recommendations of the International Ketogenic Diet Study Group Kossoff EH; Zupec-Kania BA; Amark PE; Ballaban-Gil KR; Christina Bergqvist AG; Blackford R; Buchhalter JR; Caraballo RH; Helen Cross J; Dahlin MG; Donner EJ; Klepper J; Jehle RS; Kim HD; Christiana Liu YM; Nation J; Nordli DR Jr; Pfeifer HH; Rho JM; Stafstrom CE; Thiele EA; Turner Z; Wirrell EC; Wheless JW; Veggiotti P; Vining EPEpilepsia 2009[Feb]; 50 (2): 304-17The ketogenic diet (KD) is an established, effective nonpharmacologic treatment for intractable childhood epilepsy. The KD is provided differently throughout the world, with occasionally significant variations in its administration. There exists a need for more standardized protocols and management recommendations for clinical and research use. In December 2006, The Charlie Foundation commissioned a panel comprised of 26 pediatric epileptologists and dietitians from nine countries with particular expertise using the KD. This group was created in order to create a consensus statement regarding the clinical management of the KD. Subsequently endorsed by the Practice Committee of the Child Neurology Society, this resultant manuscript addresses issues such as patient selection, pre-KD counseling and evaluation, specific dietary therapy selection, implementation, supplementation, follow-up management, adverse event monitoring, and eventual KD discontinuation. This paper highlights recommendations based on best evidence, including areas of agreement and controversy, unanswered questions, and future research.|*Diet, Ketogenic/adverse effects[MESH]|*Evidence-Based Medicine[MESH]|Anticonvulsants/therapeutic use[MESH]|Child[MESH]|Combined Modality Therapy[MESH]|Contraindications[MESH]|Dietary Supplements[MESH]|Drug Resistance[MESH]|Epilepsy/diagnosis/*diet therapy[MESH]|Humans[MESH]|Patient Care Team[MESH] |